Related Experiment Video

Updated: Jul 4, 2026

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

Short-term cognitive and affective outcomes after subthalamic deep brain stimulation for Parkinson's disease

Alexander I Tröster

    The Lancet. Neurology
    |June 10, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
    11:12

    Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

    Published on: July 16, 2014

    Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
    12:04

    Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery

    Published on: January 6, 2011

    Related Experiment Videos

    Last Updated: Jul 4, 2026

    A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
    07:14

    A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

    Published on: May 31, 2016

    Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
    11:12

    Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

    Published on: July 16, 2014

    Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
    12:04

    Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery

    Published on: January 6, 2011

    Related Concept Videos

    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

    Articles linked to this work by shared authors, journal, and citation graph.

    Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson Disease.

    JAMA neurology·2025

    Neuropsychology and Movement Disorders.

    Neurologic clinics·2024

    Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson's disease.

    Expert review of neurotherapeutics·2024

    Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia.

    Movement disorders clinical practice·2022

    Impact of Mild Cognitive Impairment on Quality of Life in Young and Typical Onset Parkinson's Disease.

    Movement disorders clinical practice·2022

    Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.

    The Lancet. Neurology·2020

    Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis.

    The Lancet. Neurology·2026

    Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

    The Lancet. Neurology·2026

    Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.

    The Lancet. Neurology·2026

    Advances in chronic subdural haematoma management: beyond the burr hole.

    The Lancet. Neurology·2026

    Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.

    The Lancet. Neurology·2026

    Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis.

    The Lancet. Neurology·2026

    Neurobehavioral Evaluation of Renin-Angiotensin System Modulators in an MPTP-Induced Model of Parkinson's Disease in Swiss Albino Mice.

    Annals of African medicine·2026

    Preparation of Decellularized Human Peripheral Nerve Grafts Using Sodium Hydroxide and Sodium Deoxycholate.

    Journal of visualized experiments : JoVE·2026

    Natural Medicines Modulating Tumor Perineural Invasion: Regulatory Mechanisms and Therapeutic Potential.

    Drug design, development and therapy·2026

    Natural killer cells in preeclampsia: an overview of current research.

    Frontiers in immunology·2026

    Crosstalk Between Cortical Plasticity and Peripheral Nervous Injury: Insights, Mechanisms, and Future Directions.

    CNS neuroscience & therapeutics·2026

    Periaqueductal gray astrocytes contribute to depression-pain comorbidity via the CXCL10/CXCR3 axis.

    Biochemical and biophysical research communications·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us